ouabain and nicorandil

ouabain has been researched along with nicorandil in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19901 (33.33)18.7374
1990's0 (0.00)18.2507
2000's2 (66.67)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Baert, B; Beetens, J; Bodé, S; De Spiegeleer, B; Deconinck, E; Lambert, J; Slegers, G; Slodicka, M; Stoppie, P; Van Gele, M; Vander Heyden, Y1
Taira, N; Yanagisawa, T1
Genka, C; Higashijima, N; Hirota, Y; Ishida, H; Nakaya, H; Nakazawa, H; Sato, T1

Other Studies

3 other study(ies) available for ouabain and nicorandil

ArticleYear
Transdermal penetration behaviour of drugs: CART-clustering, QSPR and selection of model compounds.
    Bioorganic & medicinal chemistry, 2007, Nov-15, Volume: 15, Issue:22

    Topics: Anti-Inflammatory Agents; Cell Membrane Permeability; Cluster Analysis; Drug Evaluation, Preclinical; Humans; Models, Biological; Predictive Value of Tests; Quantitative Structure-Activity Relationship; Regression Analysis; Skin; Skin Absorption

2007
Effect of 2-nicotinamidethyl nitrate (SG-75) on the membrane potential of left atrial muscle fibres of the dog. Increase in potassium conductance.
    Naunyn-Schmiedeberg's archives of pharmacology, 1980, Volume: 312, Issue:1

    Topics: Animals; Atropine; Chlorides; Dogs; Drug Interactions; Heart; In Vitro Techniques; Membrane Potentials; Methacholine Compounds; Neural Conduction; Niacinamide; Nicorandil; Nitrates; Ouabain; Potassium; Vasodilator Agents; Verapamil

1980
Nicorandil attenuates the mitochondrial Ca2+ overload with accompanying depolarization of the mitochondrial membrane in the heart.
    Naunyn-Schmiedeberg's archives of pharmacology, 2004, Volume: 369, Issue:2

    Topics: Adenosine Triphosphate; Animals; Calcium; Decanoic Acids; Glyburide; Heart Ventricles; Hydroxy Acids; In Vitro Techniques; Membrane Potentials; Mitochondria, Heart; Myocardial Contraction; Myocytes, Cardiac; Nicorandil; Ouabain; Potassium Channel Blockers; Rats; Rats, Sprague-Dawley; Vasodilator Agents

2004